Mercer Global Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Mercer Global Advisors’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$576K	Buy	5,813 +161	+3%	+$14.5K	﹤0.01%	2168
2026 Q1	$490K	Sell	5,652 -2,556	-31%	-$224K	﹤0.01%	1999
2025 Q4	$696K	Sell	8,208 -103	-1%	-$8.22K	﹤0.01%	1659
2025 Q3	$603K	Buy	8,311 +4,446	+115%	+$307K	﹤0.01%	1654
2025 Q2	$253K	Sell	3,865 -121	-3%	-$7.88K	﹤0.01%	1948
2025 Q1	$281K	Sell	3,986 -25	-0.6%	-$1.74K	﹤0.01%	1795
2024 Q4	$264K	Buy	4,011 +21	+0.5%	+$1.45K	﹤0.01%	1824
2024 Q3	$281K	Buy	3,990 +153	+4%	+$10.7K	﹤0.01%	1647
2024 Q2	$254K	Buy	3,837 +266	+7%	+$17.4K	﹤0.01%	1668
2024 Q1	$242K	Buy	+3,571	New	+$236K	﹤0.01%	1682
2023 Q2	–	Sell	-4,419	Closed	-$258K	–	1979
2023 Q1	$258K	Buy	+4,419	New	+$266K	﹤0.01%	1594

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Mercer Global Advisors's IHE Position: Q2 2026 in Review

Mercer Global Advisors increased its iShares US Pharmaceuticals ETF (IHE) stake by 2.8% in Q2 2026, buying an estimated $14.5K and bringing the position to 5,813 shares worth $576K. The position accounts for ﹤0.01% of the portfolio, ranked #2168.

Mercer Global Advisors first reported a position in IHE in Q1 2023 and has held it in 11 quarters since. The position peaked at $696K in Q4 2025. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Mercer Global Advisors held 5,813 shares of iShares US Pharmaceuticals ETF worth $576K as of Q2 2026.
Mercer Global Advisors bought 161 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $14.5K.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2168 holding.
Mercer Global Advisors first reported a position in iShares US Pharmaceuticals ETF in Q1 2023 and has held it in 11 quarters since.
Mercer Global Advisors's iShares US Pharmaceuticals ETF position peaked at $696K in Q4 2025.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.